Table 2.
Age-standardised 5-year net survival by cancer site, country, and period of diagnosis
| Australia* | Canada† | Denmark | Ireland‡ | New Zealand | Norway | UK§ | |
|---|---|---|---|---|---|---|---|
| Oesophagus | |||||||
| 1995–99 | 18·3% (16·9–19·9) | 13·5% (12·4–14·6) | 5·1% (3·9–6·6) | 10·9% (9·1–12·9) | 13·6% (11·2–16·1) | 8·7% (6·7–11·0) | 8·6% (8·2–9·0) |
| 2000–04 | 17·8% (16·5–19·2) | 14·2% (13·2–15·3) | 8·6% (7·2–10·1) | 12·8% (11·0–14·7) | 11·6% (9·6–13·9) | 9·0% (6·8–11·6) | 11·4% (11·0–11·8) |
| 2005–09 | 18·4% (17·1–19·8) | 14·8% (13·8–15·8) | 10·5% (9·0–12·0) | 17·2% (15·3–19·2) | 14·3% (12·1–16·6) | 13·2% (10·8–15·7) | 13·8% (13·4–14·2) |
| 2010–14 | 23·5% (21·6–25·4) | 16·3% (15·1–17·5) | 14·7% (12·1–17·5) | 21·9% (19·3–24·5) | 16·9% (14·3–19·7) | 19·4% (16·5–22·5) | 16·2% (15·7–16·7) |
| Absolute change | 5·2 | 2·8 | 9·6 | 11·0 | 3·3 | 10·7 | 7·6 |
| Stomach | |||||||
| 1995–99 | 25·7% (24·6–26·9) | 21·5% (20·6–22·4) | 14·0% (12·5–15·7) | 17·3% (15·5–19·1) | 21·3% (19·2–23·4) | 21·3% (19·5–23·1) | 14·1% (13·7–14·4) |
| 2000–04 | 28·1% (26·9–29·3) | 24·1% (23·2–25·1) | 15·2% (13·7–16·9) | 18·5% (16·7–20·4) | 23·7% (21·6–25·9) | 22·0% (20·2–23·9) | 16·0% (15·6–16·5) |
| 2005–09 | 29·2% (28·0–30·4) | 26·2% (25·3–27·1) | 15·7% (14·2–17·3) | 22·0% (20·2–23·9) | 24·0% (21·9–26·2) | 25·1% (23·1–27·2) | 19·0% (18·5–19·5) |
| 2010–14 | 32·8% (31·3–34·3) | 29·8% (28·6–30·9) | 22·6% (20·6–24·8) | 28·4% (26·1–30·9) | 24·5% (22·1–27·0) | 26·9% (24·6–29·3) | 20·8% (20·2–21·4) |
| Absolute change | 7·1 | 8·3 | 8·6 | 11·1 | 3·2 | 5·6 | 6·7 |
| Colon | |||||||
| 1995–99 | 59·6% (58·9–60·3) | 57·9% (57·3–58·4) | 49·1% (47·9–50·3) | 50·0% (48·5–51·6) | 59·3% (58·0–60·6) | 55·7% (54·4–57·0) | 47·0% (46·7–47·4) |
| 2000–04 | 63·5% (62·8–64·1) | 61·3% (60·7–61·8) | 53·2% (52·0–54·3) | 52·7% (51·3–54·2) | 60·3% (59·1–61·5) | 58·0% (56·8–59·1) | 51·0% (50·6–51·3) |
| 2005–09 | 67·1% (66·5–67·8) | 65·4% (64·9–65·9) | 57·5% (56·4–58·6) | 58·0% (56·7–59·3) | 61·6% (60·4–62·8) | 62·2% (61·1–63·3) | 55·3% (55·0–55·7) |
| 2010–14 | 70·8% (70·0–71·5) | 66·8% (66·2–67·4) | 65·7% (64·5–66·9) | 61·8% (60·2–63·3) | 62·1% (60·8–63·4) | 65·4% (64·2–66·5) | 58·9% (58·6–59·3) |
| Absolute change | 11·2 | 8·9 | 16·6 | 11·8 | 2·8 | 9·7 | 11·9 |
| Rectum | |||||||
| 1995–99 | 59·1% (57·9–60·3) | 57·5% (56·5–58·6) | 48·1% (46·4–49·8) | 47·6% (45·1–50·0) | 56·3% (54·0–58·6) | 57·3% (55·5–59·1) | 47·8% (47·3–48·4) |
| 2000–04 | 64·1% (63·0–65·1) | 61·6% (60·6–62·5) | 54·0% (52·3–55·7) | 51·0% (48·8–53·2) | 59·7% (57·5–61·8) | 61·5% (59·8–63·2) | 53·0% (52·4–53·5) |
| 2005–09 | 68·5% (67·5–69·5) | 65·4% (64·5–66·2) | 60·7% (59·2–62·1) | 57·1% (54·9–59·2) | 62·4% (60·4–64·4) | 65·4% (63·7–67·0) | 57·0% (56·5–57·5) |
| 2010–14 | 70·8% (69·6–72·0) | 67·0% (66·0–68·1) | 69·1% (67·4–70·8) | 62·4% (59·9–64·9) | 65·4% (63·1–67·5) | 68·8% (66·9–70·6) | 62·1% (61·5–62·6) |
| Absolute change | 11·7 | 9·5 | 21·0 | 14·8 | 9·1 | 11·5 | 14·3 |
| Pancreas | |||||||
| 1995–99 | 6·4% (5·7–7·2) | 7·0% (6·4–7·5) | 3·2% (2·5–4·0) | 5·6% (4·4–7·0) | 8·8% (7·3–10·6) | 4·4% (3·5–5·5) | 3·3% (3·0–3·5) |
| 2000–04 | 7·8% (7·1–8·6) | 7·8% (7·2–8·4) | 3·8% (3·1–4·6) | 5·9% (4·7–7·3) | 6·9% (5·6–8·5) | 4·7% (3·8–5·7) | 4·0% (3·7–4·3) |
| 2005–09 | 9·2% (8·5–10·0) | 9·6% (9·1–10·2) | 5·7% (4·9–6·5) | 7·0% (5·8–8·4) | 7·3% (6·1–8·7) | 5·9% (5·0–7·0) | 5·5% (5·2–5·8) |
| 2010–14 | 14·6% (13·5–15·7) | 11·1% (10·4–11·8) | 9·6% (8·5–10·9) | 9·6% (7·8–11·6) | 8·2% (6·8–9·7) | 9·9% (8·5–11·4) | 7·9% (7·6–8·3) |
| Absolute change | 8·2 | 4·1 | 6·4 | 4·0 | −0·6 | 5·5 | 4·6 |
| Lung | |||||||
| 1995–99 | 13·3% (12·9–13·8) | 15·4% (15·1–15·7) | 8·2% (7·7–8·7) | 9·3% (8·5–10·1) | 11·5% (10·7–12·4) | 10·8% (10·1–11·6) | 7·2% (7·0–7·3) |
| 2000–04 | 14·9% (14·5–15·4) | 16·0% (15·7–16·4) | 9·7% (9·2–10·2) | 10·1% (9·3–10·9) | 10·9% (10·2–11·7) | 11·8% (11·1–12·5) | 8·3% (8·2–8·5) |
| 2005–09 | 17·3% (16·8–17·8) | 18·5% (18·2–18·8) | 12·4% (11·9–13·0) | 13·4% (12·7–14·2) | 11·9% (11·1–12·7) | 15·4% (14·7–16·2) | 10·0% (9·8–10·2) |
| 2010–14 | 21·4% (20·8–22·0) | 21·7% (21·3–22·2) | 18·9% (18·1–19·6) | 19·8% (18·7–20·9) | 15·5% (14·5–16·5) | 20·4% (19·4–21·4) | 14·7% (14·5–15·0) |
| Absolute change | 8·1 | 6·3 | 10·7 | 10·5 | 4·0 | 9·6 | 7·5 |
| Ovary | |||||||
| 1995–99 | 35·5% (33·9–37·1) | 35·5% (34·4–36·7) | 32·0% (30·0–33·9) | 27·8% (25·2–30·5) | 31·9% (29·0–34·8) | 37·0% (34·8–39·3) | 27·3% (26·8–27·9) |
| 2000–04 | 36·2% (34·6–37·8) | 36·4% (35·3–37·5) | 34·2% (32·3–36·1) | 29·6% (27·2–32·1) | 33·5% (30·7–36·4) | 40·6% (38·4–42·8) | 29·0% (28·4–29·5) |
| 2005–09 | 40·1% (38·6–41·7) | 39·8% (38·7–40·9) | 38·3% (36·3–40·2) | 31·1% (28·7–33·5) | 32·7% (30·0–35·4) | 41·3% (39·1–43·5) | 32·1% (31·6–32·7) |
| 2010–14 | 43·2% (41·3–45·1) | 40·3% (39·0–41·6) | 42·1% (39·8–44·5) | 36·0% (33·0–38·9) | 36·3% (33·3–39·4) | 46·2% (43·6–48·8) | 37·1% (36·5–37·8) |
| Absolute change | 7·7 | 4·8 | 10·1 | 8·2 | 4·4 | 9·2 | 9·8 |
Data are 5-year age-standardised net survival estimate (95% CI) and absolute change in percentage points. Absolute change is between 1995–99 and 2010–14.
*
Australia includes New South Wales (1995–2012), Victoria, and Western Australia.
†
Canada includes Alberta, British Columbia, Manitoba, New Brunswick, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan.
‡
Ireland (1995–2013).
§
The UK includes its four consituents countries: England, Scotland, Wales, and Northern Ireland.